Tandem Pore Domain
Leak K+ currents contribute to the resting membrane potential and are important for modulation of neuronal excitability. These K+ channels are often referred to as “two-pore-domain” channels because of their predicted topology, which includes 4 transmembrane segments and two pore-forming regions in each subunit. They are open rectifiers and allow the passage of large outward currents under conditions of high internal and low external K+. In general, they show little voltage- and time-dependence. Two-pore-domain, or tandem-pore potassium channels are modulated by a host of different endogenous and clinical compounds such as neurotransmitters and anesthetics, and by physicochemical factors such as temperature, pH, oxygen tension, and osmolarity, and have multiple roles in CNS function. They also are subject to long-term regulation by changes in gene expression. At least 15 two-pore-domain channel genes from the human genome have been described. For 11 of these genes, heterologous expression leads to functional channel activity at the plasma membrane[1],[2],[3].
[1] E.A. Talley et al. Two-pore-Domain (KCNK) potassium channels: dynamic roles in neuronal function. Neuroscientist. 2003 Feb;9(1):46-56.
[2] S.A. Goldstein et al. Potassium leak channels and the KCNK family of two-P-domain subunits. Nat Rev Neurosci. 2001 Mar;2(3):175-84.
[3] C.A. Coburn et al. Discovery of a pharmacologically active antagonist of the two-pore-domain potassium channel K2P9.1 (TASK-3). ChemMedChem. 2012 Jan 2;7(1):123-33.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
3019 | A2764 dihydrochloride | Selective inhibitor of the TRESK potassium channel | €105.00 | |
3060 | A2793 | Inhibitor of the TRESK and TASK-1 potassium channel | €95.00 | |
4122 | C101248 | First potent and selective THIK-1 inhibitor | €120.00 | |
2872 | ML 335 | Selective activator of the TREK-1 and TREK-2 potassium channel | €110.00 | |
2840 | ML 365 | Potent and selective inhibitor of the TASK-1 potassium channel | €135.00 | |
2403 | PK-THPP | Potent TASK-3 antagonist with selectivity over a wide range of potassium channels | €140.00 |